The study program “Regulatory Affairs and Drug Development” was introduced in the winter of 2018 and hence just celebrated its 5th anniversary. On this occasion, an overview article about the study program was published in “Pharmazeutische Zeitung”. In addition, the journal “Deutsche Apothekerzeitung” conducted and published an interview with Dr. Anja Langeneckert and Dr. Anna Resch about the study program.
Further information on the masters’s program “Regulatory Affairs and Drug Development” on LinkedIn and the website of the Pharmaceutical Institute of the University of Freiburg.